Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Testosterone replacement therapy for bone loss prevention in HIV-infected males
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Testosterone replacement therapy for bone loss prevention in HIV-infected males'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bone Loss
75%
Bone Loss Management
100%
Endocrine Abnormalities
25%
HIV Infection
50%
HIV-infected Patients
100%
HIV-negative
25%
MEDLINE
25%
Osteopenia/osteoporosis
25%
Osteoporosis
25%
Sex Steroid Deficiency
25%
Testosterone
100%
Testosterone Replacement Therapy
100%
Medicine and Dentistry
Androgen Therapy
100%
Hormone Deficiency
25%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
50%
Osteolysis
100%
Osteopenia
25%
Osteoporosis
50%
Sex Hormone
25%
Substitution Therapy
100%
Testosterone
100%
Nursing and Health Professions
Androgen Therapy
100%
Hormone Deficiency
25%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
50%
Osteopenia
25%
Sex Hormone
25%
Substitution Therapy
100%
Testosterone
100%